{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:04:26Z","timestamp":1793747066334,"version":"4.6.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001784","name":"Pancreatic Cancer Action Network","doi-asserted-by":"publisher","award":["19-65-YAO"],"award-info":[{"award-number":["19-65-YAO"]}],"id":[{"id":"10.13039\/100001784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001784","name":"Pancreatic Cancer Action Network","doi-asserted-by":"publisher","award":["16-70-25-YAO"],"award-info":[{"award-number":["16-70-25-YAO"]}],"id":[{"id":"10.13039\/100001784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CPRIT RP121010"],"award-info":[{"award-number":["CPRIT RP121010"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002576","name":"American Cyronics Society","doi-asserted-by":"publisher","award":["R21CA2888804"],"award-info":[{"award-number":["R21CA2888804"]}],"id":[{"id":"10.13039\/100002576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008732","name":"Uehara Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007144","name":"University of Houston","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007144","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004206","name":"Osaka University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007451","name":"Cell Science Research Foundation","doi-asserted-by":"publisher","award":["1R01CA214793"],"award-info":[{"award-number":["1R01CA214793"]}],"id":[{"id":"10.13039\/100007451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007451","name":"Cell Science Research Foundation","doi-asserted-by":"publisher","award":["5P01CA11796"],"award-info":[{"award-number":["5P01CA11796"]}],"id":[{"id":"10.13039\/100007451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["HT94252311082"],"award-info":[{"award-number":["HT94252311082"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0598"],"award-info":[{"award-number":["W81XWH-20-1-0598"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP230050"],"award-info":[{"award-number":["RP230050"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.xcrm.2026.102613","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T16:07:55Z","timestamp":1771344475000},"page":"102613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"Zecheng","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelaine S.","family":"Theardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaitong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsunobu","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prapassorn","family":"Thirasastr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jangho","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangxi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long T.","family":"Vien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalida M.","family":"Wani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Heffernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Kwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio I.","family":"Wistuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio F.","family":"Draetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqiang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0172-7530","authenticated-orcid":false,"given":"Wantong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102613_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41575-019-0245-4","article-title":"Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer","volume":"17","author":"Buscail","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102613_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa2208470","article-title":"Sotorasib in KRAS p.G12C\u2013Mutated Advanced Pancreatic Cancer","volume":"388","author":"Strickler","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102613_bib3","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1056\/NEJMoa2105281","article-title":"Acquired Resistance to KRASG12C Inhibition in Cancer","volume":"384","author":"Awad","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102613_bib4","article-title":"Therapeutic targeting of syndecan-1 axis overcomes acquired resistance to KRAS-targeted therapy in gastrointestinal cancers","volume":"6","author":"Theardy","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.102613_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-019-1062-1","article-title":"Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer","volume":"568","author":"Yao","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102613_bib6","doi-asserted-by":"crossref","first-page":"C29","DOI":"10.1152\/ajpcell.00024.2022","article-title":"Targeting syndecan-1: new opportunities in cancer therapy","volume":"323","author":"Yang","year":"2022","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.xcrm.2026.102613_bib7","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1158\/1078-0432.CCR-08-2867","article-title":"The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo","volume":"15","author":"Ikeda","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102613_bib8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nrc3236","article-title":"Antibody therapy of cancer","volume":"12","author":"Scott","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2026.102613_bib9","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000473","article-title":"Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma","volume":"13","author":"Yablecovitch","year":"2022","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.xcrm.2026.102613_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102613_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.devcel.2019.05.043","article-title":"EGFR-Pak Signaling Selectively Regulates Glutamine Deprivation-Induced Macropinocytosis","volume":"50","author":"Lee","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.xcrm.2026.102613_bib12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nature12138","article-title":"Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells","volume":"497","author":"Commisso","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102613_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq5925","article-title":"Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug","volume":"8","author":"Rais","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.xcrm.2026.102613_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s43018-023-00647-3","article-title":"Targeting pancreatic cancer metabolic dependencies through glutamine antagonism","volume":"5","author":"Encarnaci\u00f3n-Rosado","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2026.102613_bib15","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44235","article-title":"Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability","volume":"8","author":"Sullivan","year":"2019","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2026.102613_bib16","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.cell.2020.02.019","article-title":"Endocytosis Inhibition in Humans to Improve Responses to ADCC-Mediating Antibodies","volume":"180","author":"Chew","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102613_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00262-021-02963-y","article-title":"Anti-disialoganglioside antibody internalization by neuroblastoma cells as a mechanism of immunotherapy resistance","volume":"71","author":"Tibbetts","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.xcrm.2026.102613_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1089\/jop.2024.0019","article-title":"PLL-g-PEG Polymer Inhibits Antibody-Drug Conjugate Uptake into Human Corneal Epithelial Cells In Vitro","volume":"40","author":"Kleinman","year":"2024","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.xcrm.2026.102613_bib19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/elsc.201600255","article-title":"Producing defucosylated antibodies with enhanced in vitro antibody-dependent cellular cytotoxicity via FUT8 knockout CHO-S cells","volume":"17","author":"Zong","year":"2017","journal-title":"Eng. Life Sci."},{"key":"10.1016\/j.xcrm.2026.102613_bib20","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1158\/0008-5472.CAN-25-2024","article-title":"KRAS Inhibition Activates an Actionable CD24 \u201cDo Not Eat Me\u201d Signal in Pancreatic Cancer.","volume":"85","author":"Wei","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102613_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s13277-012-0362-y","article-title":"Dosimetry results suggest feasibility of radioimmunotherapy using anti-CD138 (B-B4) antibody in multiple myeloma patients","volume":"33","author":"Rousseau","year":"2012","journal-title":"Tumour Biol."},{"key":"10.1016\/j.xcrm.2026.102613_bib22","doi-asserted-by":"crossref","first-page":"e794","DOI":"10.1016\/S2352-3026(21)00208-8","article-title":"Indatuximab ravtansine plus dexamethasone with lenalidomide or pomalidomide in relapsed or refractory multiple myeloma: a multicentre, phase 1\/2a study","volume":"8","author":"Kelly","year":"2021","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.xcrm.2026.102613_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/protein\/gzw040","article-title":"Novel human IgG1 and IgG4 Fc-engineered antibodies with completely abolished immune effector functions","volume":"29","author":"Schlothauer","year":"2016","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.xcrm.2026.102613_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260954","article-title":"Fc-engineered antibodies with immune effector functions completely abolished","volume":"16","author":"Wilkinson","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2026.102613_bib25","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ccr.2014.05.016","article-title":"Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy","volume":"25","author":"Ries","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102613_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41573-022-00615-z","article-title":"Rational combinations of targeted cancer therapies: background, advances and challenges","volume":"22","author":"Jin","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102613_bib27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102613_bib28","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti\u2013PD-1 Therapy","volume":"20","author":"Taube","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102613_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.968360","article-title":"4-1BB: A promising target for cancer immunotherapy","volume":"12","author":"Kim","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2026.102613_bib30","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1038\/s41598-023-34827-z","article-title":"Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer","volume":"13","author":"Koh","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102613_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7287","article-title":"The double life of a chemotherapy drug: Immunomodulatory functions of gemcitabine in cancer","volume":"13","author":"Larson","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.xcrm.2026.102613_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1226518","article-title":"Engineering NK-CAR.19 cells with the IL-15\/IL-15R\u03b1 complex improved proliferation and anti-tumor effect in vivo","volume":"14","author":"Silvestre","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102613_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2014.12.003","article-title":"Advances in the molecular functions of syndecan-1 (SDC1\/CD138) in the pathogenesis of malignancies","volume":"94","author":"Gharbaran","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.xcrm.2026.102613_bib34","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1158\/0008-5472.CAN-03-2439","article-title":"Induction of Syndecan-1 Expression in Stromal Fibroblasts Promotes Proliferation of Human Breast Cancer Cells","volume":"64","author":"Maeda","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102613_bib35","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13058-018-0995-x","article-title":"Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases","volume":"20","author":"Chute","year":"2018","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102613_bib36","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ajpath.2010.11.039","article-title":"Syndecan-1 in breast cancer stroma fibroblasts regulates extracellular matrix fiber organization and carcinoma cell motility","volume":"178","author":"Yang","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2026.102613_bib37","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1111\/bph.14429","article-title":"Identification of novel macropinocytosis inhibitors using a rational screen of Food and Drug Administration-approved drugs","volume":"175","author":"Lin","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102613_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197307","article-title":"The Immune Microenvironment in Pancreatic Cancer","volume":"21","author":"Huber","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2026.102613_bib39","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s13577-020-00362-6","article-title":"SDC1 promotes cisplatin resistance in hepatic carcinoma cells via PI3K-AKT pathway","volume":"33","author":"Yu","year":"2020","journal-title":"Hum. Cell"},{"key":"10.1016\/j.xcrm.2026.102613_bib40","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1038\/bjc.2014.493","article-title":"Shed Syndecan-1 is involved in chemotherapy resistance via the EGFR pathway in colorectal cancer","volume":"111","author":"Wang","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.xcrm.2026.102613_bib41","doi-asserted-by":"crossref","first-page":"312.e319","DOI":"10.1016\/j.urolonc.2018.03.010","article-title":"Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancer","volume":"36","author":"Szarvas","year":"2018","journal-title":"Urol. Oncol.: Seminars and Original Investigations"},{"key":"10.1016\/j.xcrm.2026.102613_bib42","first-page":"36","article-title":"Genetics and biology of pancreatic ductal adenocarcinoma","volume":"39","author":"Ying","year":"2025","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2026.102613_bib43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102613_bib44","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/2159-8290.CD-22-1066","article-title":"Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer","volume":"13","author":"Kemp","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102613_bib45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102613_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00227","article-title":"Syndecans in Inflammation at a Glance","volume":"11","author":"Gopal","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102613_bib47","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1369\/0022155420937087","article-title":"Heparanase-enhanced Shedding of Syndecan-1 and Its Role in Driving Disease Pathogenesis and Progression","volume":"68","author":"Rangarajan","year":"2020","journal-title":"J. Histochem. Cytochem."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126000303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:18:56Z","timestamp":1778919536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126000303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2666379126000303"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102613","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102613"}}